Roles of diacylglycerols and ceramides in hepatic insulin resistance

Cited by (373)

Items 301–373 of 373

1. John Yudkin’s hypothesis: sugar is a major dietary culprit in the development of cardiovascular disease
   Kenneth K. Y. Ting · 2024 · Frontiers in Nutrition
2. DPP-4 inhibition resembles exercise in preventing type 2 diabetes development by inhibiting hepatic protein kinase C ε expression in a mouse model of hyperinsulinemia
   Yupeng Li, Jing Xiao, Liang Xu, Yu Pei, Xiaofei Han, Chenxi Li, Hui Tian · 2020 · Journal of International Medical Research
3. Palmitic Acid Regulates miRNA-3148 via Insulin Receptor Substrate-1 and is Involved in Insulin Resistance
   Xiaoxi Xiang, Changwei Zhang, Daying Long · 2021 · Journal of Biomaterials and Tissue Engineering
4. Lipidomic Analysis of Adipose-Derived Extracellular Vesicles Reveals Their Potential as Lipid Mediators of Obesity-Associated Metabolic Complications
   Alexia Blandin, Grégory Hilairet, Maharajah Ponnaiah, Simon Ducheix, Isabelle Dugail, Bertrand Cariou, Marie Lhomme, Soazig Le Lay · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
5. Endogenous GDF15 and FGF21 additively alleviate hepatic steatosis and insulin resistance in obese mice
   Satish Patel, Afreen Haider, Anna Álvarez-Guaita, Guillaume Bidault, Julia S. El-Sayed Moustafa, Esther Guiu‐Jurado, John A. Tadross, James Warner, James Harrison, Sam Virtue et al. · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
6. Non-Alcoholic Fatty Liver Disease and Steatohepatitis
   Olivier Govaere, Quentin Mark Anstee · 2022 · Elsevier eBooks
7. Features of molecular mechanisms of insulin resistance pathogenesis in various tissues in obesity
   D. I. Kuzmenko, T. K. Klimenteva, Ю. Г. Самойлова, N.S. Denisov, М.В. Матвеева · 2023 · Obesity and metabolism
8. High temperature ameliorates high-fat diet-induced obesity by promoting ceramide breakdown in skeletal muscle tissue
   Qiankun Wang, Lupeng Chen, Junzhi Zhang, Yue Liu, Yi Cong Jin, Jian Xin WU, Zhuqing Ren · 2024 · Life Metabolism
9. A secondary analysis of indices of hepatic and beta cell function following 12 weeks of carbohydrate and energy restriction vs. free-living control in adults with type 2 diabetes
   Cody Garett Durrer, Hashim Islam, Haoning Howard Cen, María Dolores Moya-Garzón, Xuchao Lyu, Sean McKelvey, Joel Singer, Alan M. Batterham, Jonathan Z. Long, James D. Johnson et al. · 2024 · Nutrition & Metabolism
10. Lipidomics study of the regulatory effects of PPARδ agonist GW501516 in plasma of db/db diabetic mice
    Li Xiang, Jingchun Shi, Zifan Zhu, Yi Ru, Lin Peng, Wei Wang, Hongzhi Zhao, Runhui Liu, Yujie Pu, Lei He et al. · 2025 · Chinese Chemical Letters
11. Alginate/derivatives and their nanoparticles as anti-diabetic therapeutic via cancer, gut, liver and blood health modulation: A review
    Jia Qiang Toh, Maniphan Phonmany, Lai Wah Chan, Tin Wui Wong · 2025 · International Journal of Biological Macromolecules
12. Tissue-Specific Differences in Fatty Acid Content and Desaturase Activity Between the Liver and Spinal Cord of Diabetic ZDF Rats
    Katarína Orešanská, Mária Chomová, Janka Kubincová, Ladislav Turecký, Monika Ďurfinová · 2025 · Biology
13. Postpartum lipid dysregulation in African American women who experienced cardiometabolic complications of pregnancy
    Kristal M. Maner-Smith, Chih-Yu Chen, Zhenxin Hou, Xueyun Liu Gulbin, Jun Young Ahn, Eric A. Ortlund, Anne Lang Dunlop, Erin Poe Ferranti · 2025 · iScience
14. ToF-SIMS Reveals Metformin-Driven Restoration of Hepatic Lipid and Amino Acid Profiles in a Type 2 Diabetes Rat Model
    Magdalena Skalska, Michalina Kaźmierczak, Marcela Capcarová, Anna Kalafová, Klaudia Jaszcza, Dorota Wojtysiak · 2025 · International Journal of Molecular Sciences
15. Transcription Factors in Type 2 Diabetes: Molecular Mechanisms of Insulin Resistance and β-Cell Dysfunction
    Seyyed Amin Seyyed Rezaei, Akbar Amirfiroozy, Moein Kohkalani, Maghsoud Mehri · 2026 · Current Diabetes Reviews
16. Incretin-based therapies: a new era in metabolic liver disease management
    Sakktivel Elangovan, Chang Chuen Mark Cheah, George Boon‐Bee Goh · 2026 · Hepatoma Research
17. Nobiletin ameliorates hepatic insulin resistance by modulating the gut–liver axis
    Enhui Tang, Qianru Xiang, Nan Wang, Huangmin Zhou, Zhi Chen, Qi He, Xingfen Yang, Wenzhen Liao · 2026 · The Journal of Nutritional Biochemistry
18. Metabolic Dysfunction‐Associated Fatty Liver Disease: From Pathogenesis to Treatment
    Zhifu Cui, Xiaxia Du, Felix Kwame Amevor, Yaoyao Xia, You Yang, Lingbin Liu · 2026 · MedComm
19. A controlled-release mitochondrial protonophore attenuates early- and late-stage atheroprogression in mice
    Bernardo Gindri dos Santos, Niki F. Brisnovali, Connor Haney, Myles Coven, Homa Linda Sebzevari, Lena Gaebel, Xinbo Zhang, Jonathan Sun, Alberto Canfrán‐Duque, Noemí Rotllán et al. · 2026 · Science Translational Medicine
20. YAĞ ASİTLERİNİN TİP 2 DİYABET GELİŞİMİ ÜZERİNE ETKİLERİ
    Caner Özyıldırım · 2022 · Gazi Sağlık Bilimleri Dergisi
21. BEYOND BLOOD SUGAR CONTROL: A COMPREHENSIVE REVIEW OF DPP-4 INHIBITORS AND THEIR EXPANDING LANDSCAPE
    Parul Srivastava, Pranay Wal, Versha Chaturvedi, Ankita Wal, Ashish Srivastava · 2022 · Journal of Population Therapeutics and Clinical Pharmacology
22. Lipid metabolism and insulin sensitivity
    Xinyue Wu · 2024 · Theoretical and Natural Science
23. Hepatic lipid metabolism is altered in Ubiad1+/− mice of both sexes
    Ryoko Higa, Shirin Pourteymour, Pratibha Kolan, Simon N. Dankel, Johan Fernø, Gunnar Mellgren, Calvin Pan, Marcus Michael Seldin, Aldons Jake Lusis, Christian Andre Drevon et al. · 2025 · Scientific Reports
24. Using metabolomics to develop precision medicine strategies to treat nonalcoholic steatohepatitis
    Marta Iruarrizaga‐Lejarreta, Enara Arretxe, Cristina Alonso · 2019 · Expert Review of Precision Medicine and Drug Development
25. New insights of active constituents from herbs and nutraceuticals and their mechanisms in obesity-induced insulin resistance
    Song‐Xia Lin, Chao Wu, Xiaoyi Li, Yali Wang, Deng-Qin Lang, Chunyan Shen · 2023
26. The effect of short-term and high-intensity exercise training in plasma lipidome profiles of people living with and without HIV
    Marcos Yukio Yoshinaga, Flávio Gomez Faria, Adriano B. Chaves‐Filho, Sayuri Miyamoto, Tânia Cristina Pithon‐Curi, Giselle Cristina Bueno, Bruno Ferrari Silva, Sidney Barnabé Peres, Solange Marta Franzói de Moraes · 2025 · medRxiv
27. Nonalcoholic Fatty Liver Disease and the Risk of Incident Chronic Kidney Disease: A Meta-Analysis
    Yi‐Chao Zheng · 2018 · International Journal of Clinical and Experimental Medical Sciences
28. Managing Metabolic Health Impact of Fructose-Containing Beverages
    Ana D. Djordjevic, Nataša A. Veličković · 2019 · Elsevier eBooks
29. Adaptación y escalabilidad del framework j-everis sobre plataformas PaaS en cloud
    Alberto Prieto Leon · 2013 · RECERCAT (Consorci de Serveis Universitaris de Catalunya)
30. Identification of New IRS1 Interactors in the Regulation of Insulin Signalling and Cell Proliferation
    Scott Frendo‐Cumbo · 2021 · TSpace (University of Toronto)
31. The Effect of Eicosapentaenoic Acid on Hepatic Metabolism and Intracellular Lipid Droplet Dynamics in An in Vitro Model of Hepatic Steatosis
    Katie Morgan, Samantha Lee Suppiah, G. Masterton, Kay Samuel, Shonna Johnston, Peter Clive Hayes, Khalida Ann Lockman, Vasileios Koutsos, John N. Plevris · 2022 · Research Square
32. Energy Metabolism and Diet
    Arie G. Nieuwenhuizen, Evert M. van Schothorst · 2022 · MDPI eBooks
33. Association of type 2 diabetes mellitus and other glycemic traits with the risk of NAFLD
    Ziwei Guo, Deming Kong, Hongbo Du, Zhangjun Yun, Jiaxin Zhang, Xiaoke Li, Yongan Ye · 2022 · Research Square
34. Advances in the Study of Obesity and Diabetic Vascular Complications
    汶杉 南 · 2023 · Advances in Clinical Medicine
35. Plasma lipid trafficking in type 2 diabetes
    Isabella James, Gina Wade, Helaina C. Von Bank, Ayren McGahee, Autumn Chevalier, Paula González, Kayla Bote, James Mukasa Ntambi, Judith Simcox · 2023 · Elsevier eBooks
36. Imunologia do Diabetes Mellitus do tipo 1 e vias de glico-oxidação relacionadas a hiperglicemia
    Daniele Fernanda Renzi, Gonzalo Ogliari Dal Forno · 2023 · Research Society and Development
37. The relationship between zonulin level and indicators of carbohydrate metabolism in patients with metabolic-associated fatty liver disease combined with type 2 diabetes mellitus
    O. K. Didyk, Volodymyr V. Chernyavskyi, Vadym P. Shypulin · 2023 · GASTROENTEROLOGY
38. Einfluss des Optifast-52-Programms auf den Leberfibrosegrad von Patienten mit Adipositas
    Benjamin Peter Michael Gummlich · 2023
39. Efeitos de diferentes protocolos de treinamento físico em vias biomoleculares de controle de produção hepática de glicose e metabolismo lipídico no fígado de roedores obesos
    Rodrigo Martins Pereira · 2021
40. Effects of autumn olive berry extract on insulin resistance and non-alcoholic fatty liver in high fructose-fed rat
    Ha‐Neul Choi, Jihye Choi, Jung-In Kim · 2023 · Journal of Nutrition and Health
41. Mediated Factors Associated with Metabolic Health among Obese Adolescents
    Hadar Moran‐Lev, Ron Sternfeld, Rotem Lazmi, Rivka Ohayon, Rivka Dudi, Avivit Brener, Shira Zelber‐Sagi, Shlomi Cohen, Ronit Lubetzky, Yftach Gepner · 2024 · Research Square
42. Impact of reduced hepatic ceramide levels in high-fat diet mice on glucose metabolism
    Monika Imierska, Piotr Zabielski, Kamila Roszczyc-Owsiejczuk, Karolina Pogodzińska, Agnieszka Urszula Błachnio-Zabielska · 2024 · The Journal of Nutritional Biochemistry
43. Stronger Together: How GLP-1 RAs and SGLT-2 Inhibitors Revolutionize Type 2 Diabetes Treatment
    Hanna Sitarek, Adrianna Tabeau, Joanna Prus, Justyna Pięta, Agnieszka Pawlik, Patryk Dudek, Klaudia Łuczak, Wiktoria Ulicka, Marcel Chudzikowski, Agata Prokopiuk · 2025 · Journal of Education Health and Sport
44. Whole body and hematopoietic cell-specific deletion of G-protein coupled receptor 65 (GPR65) improves insulin sensitivity in diet-induced obese mice
    Yingjiang Zhou, EunJu Bae, Simon S. Hoffman, Da Young Oh, Gordon Ian Smith, Samuel Klein, Saswata Talukdar · 2025 · Molecular Metabolism
45. Integrated in vitro and in vivo omics analyses reveal lipid homeostasis disruption induced by widely used antimicrobial agent zinc pyrithione
    Siyu Chen, Haochun Shi, Lingzhi Cao, Congcong Wang, Shaoqi Zuo, Kun Zhang, Jiayin Dai, Yanbin Zhao · 2025 · Journal of Environmental Sciences
46. Additional file 1 of Association of non-high-density lipoprotein cholesterol trajectories with the development of non-alcoholic fatty liver disease: an epidemiological and genome-wide association study
    Lee, Jun-Hyuk, Kim, Jiyeon, Kim, Jung Oh, Kwon, Yu-Jin · 2024 · Figshare
47. Additional file 1 of A secondary analysis of indices of hepatic and beta cell function following 12 weeks of carbohydrate and energy restriction vs. free-living control in adults with type 2 diabetes
    Cody Garett Durrer, Hashim Islam, Haoning Howard Cen, María Dolores Moya-Garzón, Xuchao Lyu, McKelvey, Sean, Singer, Joel, Alan M. Batterham, Jonathan Z. Long, Johnson, James D. et al. · 2024 · Figshare
48. The Effect of Short-Term and High-Intensity Functional Circuit Training on Plasma Lipidome Profiles of People Living with and Without HIV
    Marcos Yukio Yoshinaga, Flávio Gomez Faria, Adriano B. Chaves‐Filho, Sayuri Miyamoto, TANIA CRISTINA PITHON-CURI, Giselle Cristina Bueno, Bruno Ferrari Silva, Sidney Barnabé Peres, Solange Marta Franzói de Moraes · 2025 · Metabolites
49. Heat therapy attenuates hepatic lipid accumulation via CSAD-driven metabolic reprogramming of fatty acid oxidation
    Ang Li, Yaru Dai, Yijun Luo, Ge Liang, Luolan Gui, Xinyi Hu, Xin Li, Dingkun Zhang, Wen Zheng, Lu Zhang et al. · 2026 · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
50. Association of Metabolic Dysfunction-Associated Steatohepatitis with Metabolic-Related Diseases
    Leonidas Nikolaos Diamantopoulos, Markos Kalligeros, Scott D. Isaacs, Dı́dac Mauricio · 2026 · Clinics in Liver Disease
51. Impact de surnutritions expérimentales sur le tissu adipeux chez l’homme sain
    Bérénice Segrestin · 2019
52. Insulinorésistance musculaire : rôle du métabolisme des sphingolipides
    Cécile L. Bandet · 2018 · theses.fr (ABES)
53. Homéostasie des céramides et hépatopathies métaboliques
    Marion Régnier · 2018 · theses.fr (ABES)
54. Implications du microbiote intestinal et de la pectine dans la stéato-hépatite non-alcoolique
    Camille Houron · 2020
55. La nécroptose : une nouvelle cible thérapeutique dans la stéatohépatite non-alcoolique
    Amine Majdi · 2020 · theses.fr (ABES)
56. Rôle des sphingolipides hépatiques dans la physiopathologie du diabète de type 2
    Floriane Lachkar · 2022
57. Rôle de la kinase ATR dans la progression de la stéatose hépatique non alcoolique
    Maëva Saroul-Aïnama · 2022 · theses.fr (ABES)
58. Lipidomics and machine learning revealing dysregulation of specific triacylglycerol and phosphatidylglycerol as hub lipids associated with fetal growth in gestational diabetes mellitus
    Zhenguo Lin, Lei Li, Yuhang Fan, Hao Chen, Yanhua Cai, Rongrong Yang, Mei Chen, Guolin Hong · 2026 · PeerJ
59. Calorie restriction mitigates steatotic liver disease in obese rats after bariatric surgery
    Yu‐Ning Lin, Chin-Ying Wu, Yin-Ru Hsieh, Yi-Tung Lin, Weu Wang, Chun-Chao Chang, Shih‐Yi Huang, Wei‐Yu Kao · 2026 · Nutrition Research
60. Type 2 Diabetes
    Takara Leah Stanley · 2026 · Contemporary Endocrinology
61. Rational Sequence Modification Upgrades a Food-Derived Peptide into a Stronger Dual-Functional Regulator of α-Glucosidase Activity and Insulin Resistance
    Xiang Wang, Yejun Deng, Junhao Wan, Caihong Zhang, Yong Liu, Yuechao Zhang, J. Tian, Pujun Xie, Lixin Huang · 2026 · Journal of Agricultural and Food Chemistry
62. Non-HDL-to-HDL cholesterol ratio predicts incident T2DM and CHD in non-alcoholic fatty liver disease: evidence from a large clinical cohort and NHANES
    Yanqi Kou, Yanxuan Zhong, Qing Zhang, Zhuoyan Lu, Jietao Liu, Yajuan Chen, Juntao Liang, Siyao Xu, Shiqi Zhang, Zhiying Deng et al. · 2026 · Frontiers in Nutrition
63. Research Progress on Mesenchymal Stem Cells-Derived Small Size Vesicles for the Treatment of Liver Diseases
    Chuyang Meng, Min Liu, Qianqian Qi, Lixue Cao, Qi Lei, Xifu Liu, Meng Wang · 2026 · International Journal of Nanomedicine
64. Catestatin restores cardiac metabolic flexibility and enhances mitochondrial function
    Satadeepa Kal, Venkat R. Chirasani, Nilima Biswas, Sumana Mahata, Suborno Jati, Kechun Tang, Teresa Pasqua, Ennio Avolio, Ramamurthy Chitteti, Shrabastee Chakraborty et al. · 2026 · Communications Biology
65. Moderate NEFA reprogram early follicular development and oocyte competence: evidence for a targetable redox mechanism
    Camila Cecilia Rojo-Fleming, Chiara Di Berardino, Alessia Peserico, Angelo Canciello, Chiara Camerano Spelta Rapini, Gianna Sacchetti, Giulia Capacchietti, Veronica D’Antonio, Donato Angelino, Mauro Serafini et al. · 2026 · Frontiers in Nutrition
66. Metabolic Dysfunction–Associated Steatotic Liver Disease as a Systemic Driver of Heart Failure With Preserved Ejection Fraction: Mechanistic Insights and Emerging Therapeutic Perspectives
    Junli Wu, Wenwen Zheng, Qianxian Qi, Chao‐Jie He, Changlin Zhai, Hongyan Fan · 2026 · Reviews in Cardiovascular Medicine
67. Metabolic regulation and ischemic heart disease
    H W Wang, Mei‐Yan Xu · 2026 · Elsevier eBooks
68. A Deep Learning Framework for the Discovery of Natural-Product Candidate Binders of Acetyl-CoA Carboxylase 2 (ACC2) with Potential Relevance to Cardiometabolic Lipid Metabolism
    Nada A. Alzunaidy · 2026 · Pharmaceuticals
69. SRM ‐Mediated Spermidine Synthesis Links Lipid Overload With AMPK Pathway to Regulate Hepatic Insulin Signaling and Gluconeogenesis
    Zengqi Zhao, Geye Ding, Yanan Shen, Wencong Lai, Shanshan Yang, Xiaolu Zhang, Hanjie Yu, Jianlong Du, Bingyuan Yang, X Y Tang et al. · 2026 · The FASEB Journal
70. A gut microbiome‐lipid axis in early pregnancy is associated with metabolic dysregulation and diabetes risk
    Zhonghan Sun, Chang He, Xiaonan Ma, Ping Wu, Tianlei Wang, Jiaying Yuan, Yanni Pu, Xiaofeng Zhou, Zhendong Mei, Huiling Song et al. · 2026 · iMeta
71. Mitophagy and Noncoding RNA Regulation in Type 2 Diabetes Mellitus: Molecular Mechanisms, Tissue-Specific Evidence and Translational Perspective
    Ashish Kothari, Mundakkassery Pullurmanna Narayanan, Shashi Ranjan Mani Yadav, Reena Kumari, Harsh Kumar, RADHIKA SUNIL KHERDEKAR, Shivmurat Yadav, Pallab Shaw, Baskar Chakrapani, Prawej Ansari et al. · 2026 · Biomedicines
72. Molecular signaling networks that connect tissue dysfunction to systemic insulin resistance
    Rashid Mir, Naseh A. Algehainy, Mohammed M. Jalal, Malik A. Altayar, Reema Almotairi, Faris Jamal Tayeb, Ruqaiah I. Bedaiwi, Faisal H. Altemani, Kholoud S. Almasoudi, Ibrahim Altedlawi Albalawi et al. · 2026 · Frontiers in Endocrinology
73. Integrative Multi-Omics Reveals Distinct Molecular Signatures of Metabolic Syndrome from KORA FF4 Study
    Homa Bazireh, Esienanwan Esien Efiong, Jonathan Adam, Rui Wang‐Sattler, Karsten Suhre, Jerzy Adamski, Jutta Lintelmann, Sabrina Schlesinger, Alexander Cecil, Michael A. Witting et al. · 2026 · Metabolites